Since we only studied tumor somatic alterations and did not perform germline DNA studies or conduct single-cell analysis, we are unable to demonstrate if the two co-occurring mutations in IDH1 in this patient belonged to a homozygous clone or to two different clones. Here, IDH1 is linked to neoplasm.